The price-to-earnings ratio for Hologic, Inc. (NASDAQ: HOLX) is above average at 39.65x. The 36-month beta value for HOLX is also noteworthy at 1.03. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 1 rating it as “overweight,” 11 rating it as “hold,” and 0 rating it as “sell.”

The average price estimated by analysts for HOLX is $82.01, which is $10.31 above than the current price. The public float for HOLX is 241.80M, and at present, short sellers hold a 2.95% of that float. The average trading volume of HOLX on November 17, 2023 was 1.84M shares.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


HOLX) stock’s latest price update

Hologic, Inc. (NASDAQ: HOLX)’s stock price has plunge by 0.86relation to previous closing price of 72.01. Nevertheless, the company has seen a 8.08% surge in its stock price over the last five trading sessions. Market Watch reported 2023-11-16 that Since market valuations are always changing, along with outlooks for corporate revenue and earnings, any list of favored stocks is only a snapshot. Repeating the same analysis in the near term might lead to an entirely different list of compelling names.

HOLX’s Market Performance

Hologic, Inc. (HOLX) has seen a 8.08% rise in stock performance for the week, with a 6.95% gain in the past month and a -0.71% plunge in the past quarter. The volatility ratio for the week is 2.21%, and the volatility levels for the past 30 days are at 1.79% for HOLX. The simple moving average for the last 20 days is 6.64% for HOLX stock, with a simple moving average of -6.16% for the last 200 days.

Analysts’ Opinion of HOLX

Many brokerage firms have already submitted their reports for HOLX stocks, with Needham repeating the rating for HOLX by listing it as a “Buy.” The predicted price for HOLX in the upcoming period, according to Needham is $95 based on the research report published on July 14, 2023 of the current year 2023.

HOLX Trading at 4.57% from the 50-Day Moving Average

After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.35% of loss for the given period.

Volatility was left at 1.79%, however, over the last 30 days, the volatility rate increased by 2.21%, as shares surge +7.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.43% lower at present.

During the last 5 trading sessions, HOLX rose by +8.08%, which changed the moving average for the period of 200-days by -12.26% in comparison to the 20-day moving average, which settled at $68.35. In addition, Hologic, Inc. saw -2.91% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HOLX starting from GARRETT SCOTT T, who sale 10,000 shares at the price of $79.72 back on Jun 15. After this action, GARRETT SCOTT T now owns 57,039 shares of Hologic, Inc., valued at $797,240 using the latest closing price.

Mitchell Essex D, the Div. President, GYN Surgical of Hologic, Inc., sale 2,390 shares at $83.73 during a trade that took place back on May 05, which means that Mitchell Essex D is holding 7,212 shares at $200,115 based on the most recent closing price.

Stock Fundamentals for HOLX

Current profitability levels for the company are sitting at:

The net margin for Hologic, Inc. stands at +11.31. The total capital return value is set at 12.04, while invested capital returns managed to touch 5.96. Equity return is now at value 9.22, with 5.01 for asset returns.

Based on Hologic, Inc. (HOLX), the company’s capital structure generated 56.17 points at debt to equity in total, while total debt to capital is 35.97. Total debt to assets is 30.84, with long-term debt to equity ratio resting at 50.45. Finally, the long-term debt to capital ratio is 32.31.

When we switch over and look at the enterprise to sales, we see a ratio of 4.40, with the company’s debt to enterprise value settled at 0.16. The receivables turnover for the company is 6.48 and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.47.


In summary, Hologic, Inc. (HOLX) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.